LI
REGN icon

LMCG Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

LMCG Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23M Sell
36,837
-2,142
-5% -$1.46M 1.23% 23
2026
Q1 		$30.1M Sell
38,979
-842
-2% -$645K 1.79% 10
2025
Q4 		$30.7M Buy
39,821
+3,556
+10% +$2.41M 1.76% 10
2025
Q3 		$20.4M Buy
36,265
+2,668
+8% +$1.51M 1.2% 20
2025
Q2 		$17.6M Buy
33,597
+19,116
+132% +$10.7M 1.11% 22
2025
Q1 		$9.18M Buy
14,481
+10,110
+231% +$6.95M 0.61% 55
2024
Q4 		$3.11M Sell
4,371
-453
-9% -$380K 0.19% 121
2024
Q3 		$5.07M Sell
4,824
-8
-0.2% -$8.9K 0.3% 96
2024
Q2 		$5.08M Buy
4,832
+215
+5% +$208K 0.3% 100
2024
Q1 		$4.44M Sell
4,617
-15
-0.3% -$14.3K 0.26% 108
2023
Q4 		$4.07M Sell
4,632
-14
-0.3% -$11.5K 0.25% 109
2023
Q3 		$3.82M Sell
4,646
-110
-2% -$86.5K 0.26% 110
2023
Q2 		$3.42M Sell
4,756
-129
-3% -$99.5K 0.22% 115
2023
Q1 		$4.01M Buy
4,885
+70
+1% +$52.8K 0.27% 104
2022
Q4 		$3.47M Buy
4,815
+59
+1% +$43.5K 0.24% 112
2022
Q3 		$3.28M Buy
4,756
+48
+1% +$30.2K 0.24% 117
2022
Q2 		$2.78M Buy
4,708
+78
+2% +$50.7K 0.19% 131
2022
Q1 		$3.23M Buy
+4,630
New +$2.93M 0.19% 134

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

LMCG Investments's REGN Position: Q2 2026 in Review

LMCG Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 5.5% in Q2 2026, selling an estimated $1.46M and leaving 36,837 shares worth $23M. The position accounts for 1.23% of the portfolio, ranked #23.

LMCG Investments first reported a position in REGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $30.7M in Q4 2025. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • LMCG Investments held 36,837 shares of Regeneron Pharmaceuticals worth $23M as of Q2 2026.
  • LMCG Investments sold 2,142 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.46M.
  • Regeneron Pharmaceuticals made up 1.23% of LMCG Investments's portfolio in Q2 2026, its #23 holding.
  • LMCG Investments first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • LMCG Investments's Regeneron Pharmaceuticals position peaked at $30.7M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.